Wnt3a regulates proliferation, apoptosis and function of pancreatic NIT-1 beta cells via activation of IRS2/PI3K signaling

Journal of Cellular Biochemistry

Volumn 114, Issue 7, 2013, Pages 1488-1497

  Gui, Shuyan ^a   Yuan, Gang ^a   Wang, Lu ^a   Zhou, Lili ^a   Xue, Ying ^a   Yu, Yikai ^a   Zhang, Jianhua ^a   Zhang, Muxun ^a   Yang, Yan ^a   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

APOPTOSIS; BETA CELL; INSULIN RECEPTOR SUBSTRATE (IRS2); PI3K Akt; PROLIFERATION; Wnt SIGNALING; Wnt3a

Indexed keywords

BROXURIDINE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WNT3A PROTEIN; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; FLOW CYTOMETRY; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT3A PROTEIN;

EID: 84877687941     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24490     Document Type: Article

References (38)

1. Akiyama T,. 2000. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 11: 273-282.
2. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S,. 2005. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280: 41342-41351. (Pubitemid 41832191)
3. Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ,. 2003. Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes 52: 974-983. (Pubitemid 36388732)
4. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR,. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569. (Pubitemid 128379082)
5. Dahlgren A, Zethelius B, Jensevik K, Syvanen AC, Berne C,. 2007. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. Diabetologia 50: 1852-1857. (Pubitemid 47222863)
6. Diehl JA, Cheng M, Roussel MF, Sherr CJ,. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511. (Pubitemid 28553242)
7. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K,. 2006. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
8. Hamaguchi K, Gaskins HR, Leiter EH,. 1991. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40: 842-849.
9. Hattersley AT,. 2007. Prime suspect: The TCF7L2 gene and type 2 diabetes risk. J Clin Invest 117: 2077-2079. (Pubitemid 47219548)
10. Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F, Machicao F, Stefan N, Claussen CD, Haring HU, Fritsche A, Staiger H,. 2010. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes 59: 747-750.
11. Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, White MF,. 2003. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112: 1521-1532. (Pubitemid 38056278)
12. Hie M, Iitsuka N, Otsuka T, Tsukamoto I,. 2011. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28 (3): 455-462.
13. Jeon SH, Yoon JY, Park YN, Jeong WJ, Kim S, Jho EH, Surh YJ, Choi KY,. 2007. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin. J Biol Chem 282: 14482-14492. (Pubitemid 47100480)
14. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU,. 1985. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4: 110-125.
15. Lingohr MK, Buettner R, Rhodes CJ,. 2002. Pancreatic beta-cell growth and survival-A role in obesity-linked type 2 diabetes ? Trends Mol Med 8: 375-384. (Pubitemid 34826723)
16. Lingohr MK, Dickson LM, Wrede CE, Briaud I, McCuaig JF, Myers MG, Jr., Rhodes CJ,. 2003. Decreasing IRS-2 expression in pancreatic beta-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression. Mol Cell Endocrinol 209: 17-31. (Pubitemid 37353079)
17. Liu Z, Habener JF,. 2008. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283: 8723-8735.
18. Mao J, Wang J, Liu B, Pan W, Farr GH, III, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D,. 2001. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809. (Pubitemid 32436440)
19. Mohanty S, Spinas GA, Maedler K, Zuellig RA, Lehmann R, Donath MY, Trub T, Niessen M,. 2005. Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Exp Cell Res 303: 68-78. (Pubitemid 39575145)
20. Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama T,. 2004. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23: 8520-8526. (Pubitemid 39540802)
21. Norton L, Fourcaudot M, Abdul-Ghani MA, Winnier D, Mehta FF, Jenkinson CP, Defronzo RA,. 2011. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia 54: 3132-3142.
22. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krtzfeldt J, Yin C, Holzenberger M, Stoffel M, Kulkarni RN,. 2007. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 104: 8977-8982. (Pubitemid 47175422)
23. Park S, Dong X, Fisher TL, Dunn S, Omer AK, Weir G, White MF,. 2006. Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J Biol Chem 281: 1159-1168.
24. Patel S, Doble B, Woodgett JR,. 2004. Glycogen synthase kinase-3 in insulin and Wnt signalling: A double-edged sword ? Biochem Soc Trans 32: 803-808. (Pubitemid 39524384)
25. Pirola L, Bonnafous S, Johnston AM, Chaussade C, Portis F, Van Obberghen E,. 2003. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 278: 15641-15651. (Pubitemid 36799674)
26. Rhodes CJ, White MF,. 2002. Molecular insights into insulin action and secretion. Eur J Clin Invest 32 (Suppl 3): 3-13. (Pubitemid 41704995)
27. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, Taketo MM, Nusse R, Hebrok M, Kim SK,. 2007. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 104: 6247-6252. (Pubitemid 47186080)
28. Schinner S, Ulgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A, Scherbaum WA,. 2008. Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 51: 147-154. (Pubitemid 50002200)
29. Sherr CJ,. 2001. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2: 731-737. (Pubitemid 33679835)
30. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K,. 2008. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57: 645-653.
31. Stocker H, Hafen E,. 2000. Genetic control of cell size. Curr Opin Genet Dev 10: 529-535.
32. Suzuki R, Tobe K, Terauchi Y, Komeda K, Kubota N, Eto K, Yamauchi T, Azuma K, Kaneto H, Taguchi T, Koga T, German MS, Watada H, Kawamori R, Wright CV, Kajimoto Y, Kimura S, Nagai R, Kadowaki T,. 2003. Pdx1 expression in Irs2-deficient mouse beta-cells is regulated in a strain-dependent manner. J Biol Chem 278: 43691-43698. (Pubitemid 37345996)
33. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A,. 2001. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50 (Suppl 1): S154-S159. (Pubitemid 32148243)
34. Welters HJ, Kulkarni RN,. 2008. Wnt signaling: Relevance to beta-cell biology and diabetes. Trends Endocrinol Metab 19: 349-355.
35. Yi F, Sun J, Lim GE, Fantus IG, Brubaker PL, Jin T,. 2008. Cross talk between the insulin and Wnt signaling pathways: Evidence from intestinal endocrine L cells. Endocrinology 149: 2341-2351. (Pubitemid 351574509)
36. Yoon JC, Ng A, Kim BH, Bianco A, Xavier RJ, Elledge SJ,. 2011. Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev 24: 1507-1518.
37. Yun MS, Kim SE, Jeon SH, Lee JS, Choi KY,. 2005. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 118: 313-322. (Pubitemid 40277344)
38. Zimmet P, Alberti KG, Shaw J,. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782-787. (Pubitemid 34000780)